Pharma Stocks
-
Tempus AI (TEM) Stock: Why Big Pharma Is Betting Big on This AI Platform
TLDR Tempus AI total contract value exceeded $1.1 billion, marking highest level in company history Company signed 70 data agreements…
Read More » -
Jenburkt Pharmaceuticals Downgraded to Sell Amid Technica…
Technical Trends Turn Bearish The primary catalyst for the downgrade lies in the technical analysis of Jenburkt Pharmaceuticals’ stock price…
Read More » -
Should NewAmsterdam’s Multi-Indication Obicetrapib Strategy Reshape How NAMS Investors View Pipeline Concentration?
NewAmsterdam Pharma recently outlined its late-stage plans for obicetrapib, including an expected EMA approval decision in the second half of…
Read More » -
Did COACH Trial Combo Data and FDA Priority Review Just Shift Ascendis Pharma’s (ASND) Investment Narrative?
Ascendis Pharma recently reported past Week 52 topline results from its Phase 2 COACH trial, showing that once-weekly TransCon CNP…
Read More » -
Optimistic Investors Push Sumitomo Pharma Co., Ltd. (TSE:4506) Shares Up 26% But Growth Is Lacking
Despite an already strong run, Sumitomo Pharma Co., Ltd. (TSE:4506) shares have been powering on, with a gain of 26%…
Read More » -
Truist Raises PT on Amneal Pharmaceuticals (AMRX) to $15 From $14
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is one of the best performing pharma stocks in 2025. On January 7, Truist raised the…
Read More » -
Is This ‘Boring’ Pharma Stock a Secret Power Play?
Everyone’s chasing hype stocks, but Sanofi S.A. is quietly moving the health game. Is this a sneaky must-cop or a…
Read More » -
Is This Pharma Giant a Silent Market Cheat Code?
Takeda looks boring on the surface, but the stock, the pipeline, and the US moves might be the sleeper play…
Read More » -
Takeda Pharmaceutical (TSE:4502) Valuation Check As Shares Show Strength Over Recent Periods
Takeda Pharmaceutical (TSE:4502) has drawn investor attention after recent share price moves, with the stock showing different return profiles over…
Read More » -
What’s Going On With ARS Pharmaceuticals Stock Friday? – ARS Pharmaceuticals (NASDAQ:SPRY)
ARS Pharmaceuticals Inc. (NASDAQ:SPRY) stock rose Friday in reaction to a negative update for its rival Aquestive Therapeutics Inc. (NASDAQ:AQST).…
Read More »